Search Results

There are 10986 results for: content related to: Accumulation of anthocyanins in tomato skin extends shelf life

  1. You have free access to this content
    Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 330–338, E Martinez, A Gonzalez-Cordon, E Ferrer, P Domingo, E Negredo, F Gutierrez, J Portilla, A Curran, D Podzamczer, J Murillas, JI Bernardino, I Santos, JA Carton, J Peraire, J Pich, I Perez, JM Gatell and for the ATADAR Study Group

    Version of Record online : 12 JAN 2014, DOI: 10.1111/hiv.12121

  2. A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 4, April 2009, Pages: 402–408, A Avihingsanon, J van der Lugt, SJ Kerr, M Gorowara, S Chanmano, P Ohata, J Lange, DA Cooper, P Phanuphak, DM Burger and K Ruxrungtham

    Version of Record online : 31 DEC 2008, DOI: 10.1038/clpt.2008.244

  3. You have full text access to this OnlineOpen article
    The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir

    HIV Medicine

    Volume 17, Issue 2, February 2016, Pages: 106–117, DA Wohl, L Bhatti, CB Small, H Edelstein, HH Zhao, DA Margolis, E DeJesus, WG Weinberg, LL Ross and MS Shaefer

    Version of Record online : 14 JUL 2015, DOI: 10.1111/hiv.12281

  4. You have free access to this content
    Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy

    HIV Medicine

    Volume 15, Issue 10, November 2014, Pages: 604–610, LJ Else, V Jackson, M Brennan, DJ Back, SH Khoo, S Coulter-Smith and JS Lambert

    Version of Record online : 14 MAY 2014, DOI: 10.1111/hiv.12164

  5. Pharmacokinetics and Pharmacodynamics of Atazanavir-containing Antiretroviral Regimens, with or without Ritonavir, in Patients who are HIV-positive and Treatment-naïve

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 3, March 2013, Pages: 284–294, Richard J. Bertz, Anna Persson, Ellen Chung, Li Zhu, Jenny Zhang, Donnie McGrath and Dennis Grasela

    Version of Record online : 1 MAR 2013, DOI: 10.1002/phar.1205

  6. Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients

    British Journal of Clinical Pharmacology

    Volume 82, Issue 6, December 2016, Pages: 1528–1538, José Moltó, Javier A. Estévez, Cristina Miranda, Samandhy Cedeño, Bonaventura Clotet and Marta Valle

    Version of Record online : 13 SEP 2016, DOI: 10.1111/bcp.13072

  7. A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients

    International Journal of Clinical Practice

    Volume 65, Issue 12, December 2011, Pages: 1240–1249, E. DeJesus, A. Mills, L. Bhatti, C. Conner and S. Storfer

    Version of Record online : 14 OCT 2011, DOI: 10.1111/j.1742-1241.2011.02807.x

  8. Evaluation of Atazanavir and Darunavir Interactions with Lipids for Developing pH-Responsive Anti-HIV Drug Combination Nanoparticles

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 8, August 2014, Pages: 2520–2529, Jinghua Duan, Jennifer P. Freeling, Josefin Koehn, Cuiling Shu and Rodney J. Y. Ho

    Version of Record online : 19 JUN 2014, DOI: 10.1002/jps.24046

  9. GluN2B N-methyl-D-aspartic acid receptor subunit mediates atorvastatin-Induced neuroprotection after focal cerebral ischemia

    Journal of Neuroscience Research

    Volume 92, Issue 11, November 2014, Pages: 1529–1548, Johanna Andrea Gutierrez-Vargas, Juan Ignacio Muñoz-Manco, Luis Miguel Garcia-Segura and Gloria Patricia Cardona-Gómez

    Version of Record online : 17 JUN 2014, DOI: 10.1002/jnr.23426

  10. You have free access to this content
    Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572

    British Journal of Clinical Pharmacology

    Volume 72, Issue 1, July 2011, Pages: 103–108, Ivy Song, Julie Borland, Shuguang Chen, Yu Lou, Amanda Peppercorn, Toshihiro Wajima, Sherene Min and Stephen C. Piscitelli

    Version of Record online : 9 JUN 2011, DOI: 10.1111/j.1365-2125.2011.03947.x

  11. The Effect of Atazanavir and Atazanavir/Ritonavir on UDP-Glucuronosyltransferase Using Lamotrigine as a Phenotypic Probe

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 6, December 2008, Pages: 698–703, DM Burger, A Huisman, N Van Ewijk, H Neisingh, P Van Uden, GA Rongen, P Koopmans and RJ Bertz

    Version of Record online : 4 JUN 2008, DOI: 10.1038/clpt.2008.106

  12. You have free access to this content
    A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction

    HIV Medicine

    Volume 15, Issue 5, May 2014, Pages: 301–310, J Baril, B Conway, P Giguère, N Ferko, S Hollmann and JB Angel

    Version of Record online : 9 DEC 2013, DOI: 10.1111/hiv.12118

  13. Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats

    Journal of Periodontal Research

    Volume 49, Issue 1, February 2014, Pages: 45–54, P. Goes, I. M. Melo, L. M. C. M. Silva, N. M. B. Benevides, N. M. N. Alencar, R. A. Ribeiro and V. Lima

    Version of Record online : 7 JUN 2013, DOI: 10.1111/jre.12077

  14. You have free access to this content
    Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic

    British Journal of Clinical Pharmacology

    Volume 60, Issue 3, September 2005, Pages: 291–299, John E. Ray, Debbie Marriott, Mark T. Bloch and Andrew J. McLachlan

    Version of Record online : 6 MAY 2005, DOI: 10.1111/j.1365-2125.2005.02413.x

  15. You have full text access to this Open Access content
    Possible Emergence of Drug-Resistant Variants of Babesia gibsoni in Clinical Cases Treated with Atovaquone and Azithromycin

    Journal of Veterinary Internal Medicine

    Volume 23, Issue 3, May/June 2009, Pages: 493–498, M. Sakuma, A. Setoguchi and Y. Endo

    Version of Record online : 13 APR 2009, DOI: 10.1111/j.1939-1676.2009.0300.x

  16. Pharmacokinetics of Saquinavir With Atazanavir or Low-Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 2, February 2007, Pages: 201–208, Dr Jennifer R. King, Dr Thomas N. Kakuda, Ms Sunita Paul, Dr Man Ming Tse, Dr Edward P. Acosta and Dr Stephen L. Becker

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296763

  17. You have free access to this content
    Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

    HIV Medicine

    Volume 11, Issue 5, May 2010, Pages: 326–333, M Fabbiani, S Di Giambenedetto, E Ragazzoni, M Colafigli, M Prosperi, R Cauda, P Navarra and A De Luca

    Version of Record online : 11 JAN 2010, DOI: 10.1111/j.1468-1293.2009.00785.x

  18. Drug–drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 8, November 2012, Pages: 455–465, Rahul Vats, Kanthikiran V. S. Varanasi, Rambabu Arla, Sridhar Veeraraghvan and Shraddha Rajak

    Version of Record online : 7 OCT 2012, DOI: 10.1002/bdd.1812

  19. Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates

    HIV Medicine

    Volume 17, Issue 1, January 2016, Pages: 28–35, MEO Perry, GP Taylor, CA Sabin, K Conway, S Flanagan, E Dwyer, J Stevenson, L Mulka, A McKendry, E Williams, A Barbour, S Dermont, S Roedling, R Shah, J Anderson, M Rodgers, C Wood, L Sarner, P Hay, D Hawkins and A deRuiter

    Version of Record online : 22 JUL 2015, DOI: 10.1111/hiv.12277

  20. Population Pharmacokinetics of Atorvastatin and Its Active Metabolites in Children and Adolescents With Heterozygous Familial Hypercholesterolemia: Selective Use of Informative Prior Distributions from Adults

    The Journal of Clinical Pharmacology

    Volume 53, Issue 5, May 2013, Pages: 505–516, William Knebel, Marc R. Gastonguay, Bimal Malhotra, Ahmed El-Tahtawy, Frank Jen and Kuan Gandelman

    Version of Record online : 4 FEB 2013, DOI: 10.1002/jcph.66